Critical pathogenic steps to high risk Helicobacter pylori gastritis and gastric carcinogenesis

被引:17
|
作者
Lee, Inchul [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul 138736, South Korea
关键词
Helicobacter pylori; Atypical Malgun cell; Neutrophilic foveolitis; Stomach; Cancer; Gastritis; Pathology; Premalignant; CLEAR CELL-CHANGE; STOMACH; SYSTEM;
D O I
10.3748/wjg.v20.i21.6412
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Helicobacter pylori (H. pylori) gastritis may progress to high risk gastropathy and cancer. However, the pathological progression has not been characterized in detail. H. pylori induce persistent inflammatory infiltration. Neutrophils are unique in that they directly infiltrate into foveolar epithelium aiming the proliferative zone specifically. Neutrophilic proliferative zone foveolitis is a critical pathogenic step in H. pylori gastritis inducing intensive epithelial damage. Epithelial cells carrying accumulated genomic damage and mutations show the Malgun (clear) cell change, characterized by large clear nucleus and prominent nucleolus. Malgun cells further undergo atypical changes, showing nuclear folding, coarse chromatin, and multiple nucleoli. The atypical Malgun cell (AMC) change is a novel premalignant condition in high risk gastropathy, which may progress and undergo malignant transformation directly. The patho-biological significance of AMC in gastric carcinogenesis is reviewed. A new diagnosis system of gastritis is proposed based on the critical pathologic steps classifying low and high risk gastritis for separate treatment modality. It is suggested that the regulation of H. pylori-induced neutrophilic foveolitis might be a future therapeutic goal replacing bactericidal antibiotics approach. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:6412 / 6419
页数:8
相关论文
共 50 条
  • [31] ABO Genotype and the Risk of Gastric Cancer, Atrophic Gastritis, and Helicobacter pylori Infection
    Nakao, Makoto
    Matsuo, Keitaro
    Ito, Hidemi
    Shitara, Kohei
    Hosono, Satoyo
    Watanabe, Miki
    Ito, Seiji
    Sawaki, Akira
    Iida, Shinsuke
    Sato, Shigeki
    Yatabe, Yasushi
    Yamao, Kenji
    Ueda, Ryuzo
    Tajima, Kazuo
    Hamajima, Nobuyuki
    Tanaka, Hideo
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (08) : 1665 - 1672
  • [32] The role of Helicobacter pylori CagA in gastric carcinogenesis
    Hatakeyama, Masanori
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 84 (04) : 301 - 308
  • [33] Editorial: The role of Helicobacter pylori in gastric carcinogenesis
    Torres, Javier
    Ferreira, Rui M.
    Kato, Ikuko
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [34] The Role of Helicobacter pylori CagA in Gastric Carcinogenesis
    Masanori Hatakeyama
    International Journal of Hematology, 2006, 84 : 301 - 308
  • [35] Helicobacter pylori virulence factors in gastric carcinogenesis
    Wen, Sicheng
    Moss, Steven F.
    CANCER LETTERS, 2009, 282 (01) : 1 - 8
  • [37] Experimental gastric carcinogenesis related to Helicobacter pylori
    Shimoyama, T
    Fukuda, Y
    Sakagami, T
    Yamamoto, N
    Kashihara, W
    Okui, M
    Tanida, N
    Tamura, G
    HEPATO-GASTROENTEROLOGY, 2001, 48 (42) : 1531 - 1536
  • [38] Helicobacter pylori infection in gastric carcinogenesis.
    Myllykangas, S
    Monni, O
    Rautelin, H
    Knuutila, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 245 - 245
  • [39] Relatedness of Helicobacter pylori populations to gastric carcinogenesis
    Quan-Jiang Dong
    Shu-Hui Zhan
    Li-Li Wang
    Yong-Ning Xin
    Man Jiang
    Shi-Ying Xuan
    World Journal of Gastroenterology, 2012, (45) : 6571 - 6576
  • [40] Helicobacter pylori Effects On Carcinogenesis in the Gastric Remnant
    Fukuhara, Kenichiro
    Ohmura, Toru
    Katsuragi, Kunihiro
    GASTROENTEROLOGY, 2009, 136 (05) : A765 - A765